These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27057625)

  • 1. Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.
    Kong LM; Yao L; Lu N; Dong YL; Zhang J; Wang YQ; Liu L; Zhang HL; Huang JG; Liao CG
    Oncotarget; 2016 May; 7(19):27975-87. PubMed ID: 27057625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
    Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
    Kong X; Xu P; Cai WJ; Wang HG; Li BB; Huang GL; He ZW; Chen G; Ye CG
    BMC Cancer; 2018 Apr; 18(1):419. PubMed ID: 29653560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
    Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
    J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.
    Zhao G; Han C; Zhang Z; Wang L; Xu J
    Biochem Biophys Res Commun; 2017 Aug; 490(2):371-377. PubMed ID: 28623129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
    Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
    Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
    Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
    Wang F; Zhang B; Xu X; Zhu L; Zhu X
    Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
    Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
    Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
    Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
    Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
    Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
    Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
    J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
    Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
    Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
    Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.